Literature DB >> 588291

Inhibition by pargyline of cardiovascular amine oxidase activity.

J A Fuentes, N H Neff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 588291     DOI: 10.1016/0006-2952(77)90259-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  Metabolism of amines in the isolated perfused mesenteric arterial bed of the rat.

Authors:  J Elliott; B A Callingham; D F Sharman
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

2.  Localization of monoamine oxidase of type A and B in blood vessels with different innervation patterns.

Authors:  M M Caramona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

3.  Deamination of released 3H-noradrenaline in the canine saphenous vein.

Authors:  T J Verbeuren; P M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

4.  Allylamine cardiotoxicity: II. Histopathology and histochemistry.

Authors:  P J Boor; T J Nelson; P Chieco
Journal:  Am J Pathol       Date:  1980-09       Impact factor: 4.307

5.  The contribution by monoamine oxidase and catechol-O-methyltransferase to the total-body and pulmonary plasma clearance of catecholamines.

Authors:  B Friedgen; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

6.  The interaction of hydralazine with a semicarbazide-sensitive amine oxidase in brown adipose tissue of the rat. Its use as a radioactive ligand for the enzyme.

Authors:  M A Barrand; B A Callingham
Journal:  Biochem J       Date:  1985-12-01       Impact factor: 3.857

7.  Solubilization and some properties of a semicarbazide-sensitive amine oxidase in brown adipose tissue of the rat.

Authors:  M A Barrand; B A Callingham
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

8.  Treatment with clorgyline and pargyline differentially decreases clonidine-induced hypotension and bradycardia.

Authors:  J S Gutkind; M A Enero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.